$BLUE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in bluebird bio, Inc.. Get notifications about new insider transactions in bluebird bio, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 13 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 05 2017 | BLUE | bluebird bio, Inc. | HIGH SUSANNA GATTI | Chief Operating Off ... | Sell | S | 172.15 | 1,282 | 220,696 | 13,718 | 15 K to 13.7 K (-8.55 %) |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 22,000 | |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 173.58 | 400 | 69,430 | 26,484 | 26.9 K to 26.5 K (-1.49 %) |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 172.84 | 900 | 155,557 | 26,884 | 27.8 K to 26.9 K (-3.24 %) |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 171.82 | 950 | 163,224 | 27,784 | 28.7 K to 27.8 K (-3.31 %) |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 28,734 | 27.5 K to 28.7 K (+4.55 %) |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 4,000 | 22,002 | 79,151 | |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 173.48 | 800 | 138,780 | 15,977 | 16.8 K to 16 K (-4.77 %) |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 172.77 | 1,335 | 230,650 | 16,777 | 18.1 K to 16.8 K (-7.37 %) |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 171.72 | 1,865 | 320,250 | 18,112 | 20 K to 18.1 K (-9.34 %) |
| Dec 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 4,000 | 22,002 | 19,977 | 16 K to 20 K (+25.04 %) |
| Nov 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 24.47 | 7,829 | 191,576 | 42,171 | |
| Nov 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 578 | 3,179 | 27,007 | |
| Nov 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 2.09 | 1,493 | 3,115 | 8,743 | |
| Nov 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 150.18 | 1,200 | 180,220 | 27,305 | 28.5 K to 27.3 K (-4.21 %) |
| Nov 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 149.74 | 6,600 | 988,260 | 28,505 | 35.1 K to 28.5 K (-18.80 %) |
| Nov 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 148.76 | 2,100 | 312,385 | 35,105 | 37.2 K to 35.1 K (-5.64 %) |
| Nov 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 24.47 | 7,829 | 191,576 | 37,205 | 29.4 K to 37.2 K (+26.65 %) |
| Nov 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 578 | 3,179 | 29,376 | 28.8 K to 29.4 K (+2.01 %) |
| Nov 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 2.09 | 1,493 | 3,115 | 28,798 | 27.3 K to 28.8 K (+5.47 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 35,000 | 192,514 | 27,585 | |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 153.10 | 974 | 149,115 | 27,305 | 28.3 K to 27.3 K (-3.44 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 152.30 | 7,789 | 1,186,282 | 28,279 | 36.1 K to 28.3 K (-21.60 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 151.45 | 15,462 | 2,341,748 | 36,068 | 51.5 K to 36.1 K (-30.01 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 150.46 | 10,775 | 1,621,181 | 51,530 | 62.3 K to 51.5 K (-17.29 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 35,000 | 192,514 | 62,305 | 27.3 K to 62.3 K (+128.18 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | M | 5.50 | 2,127 | 11,699 | 241,228 | |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 145.17 | 2,127 | 308,779 | 255,359 | 257.5 K to 255.4 K (-0.83 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Buy | M | 5.50 | 2,127 | 11,699 | 257,486 | 255.4 K to 257.5 K (+0.83 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 23,250 | |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 145.04 | 500 | 72,520 | 27,484 | 28 K to 27.5 K (-1.79 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 144.10 | 1,750 | 252,170 | 27,984 | 29.7 K to 28 K (-5.89 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 29,734 | 28.5 K to 29.7 K (+4.39 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 4,000 | 22,002 | 83,151 | |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 146.14 | 1,100 | 160,750 | 15,977 | 17.1 K to 16 K (-6.44 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 145.39 | 1,272 | 184,930 | 17,077 | 18.3 K to 17.1 K (-6.93 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 144.44 | 1,628 | 235,142 | 18,349 | 20 K to 18.3 K (-8.15 %) |
| Nov 03 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 4,000 | 22,002 | 19,977 | 16 K to 20 K (+25.04 %) |
| Oct 24 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 145.26 | 3,700 | 537,455 | 255,359 | 259.1 K to 255.4 K (-1.43 %) |
| Oct 24 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 145.02 | 3,350 | 485,813 | 259,059 | 262.4 K to 259.1 K (-1.28 %) |
| Oct 19 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 145.05 | 10,823 | 1,569,840 | 262,409 | 273.2 K to 262.4 K (-3.96 %) |
| Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 4,900 | 26,952 | 62,585 | |
| Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 131.80 | 500 | 65,900 | 27,305 | 27.8 K to 27.3 K (-1.80 %) |
| Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 130.27 | 1,600 | 208,425 | 27,805 | 29.4 K to 27.8 K (-5.44 %) |
| Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 129.43 | 2,800 | 362,399 | 29,405 | 32.2 K to 29.4 K (-8.69 %) |
| Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 4,900 | 26,952 | 32,205 | 27.3 K to 32.2 K (+17.95 %) |
| Oct 04 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 24,500 | |
| Oct 04 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 132.15 | 50 | 6,608 | 28,484 | 28.5 K to 28.5 K (-0.18 %) |
| Oct 04 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 131.82 | 2,200 | 289,995 | 28,534 | 30.7 K to 28.5 K (-7.16 %) |
| Oct 04 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 30,734 | 29.5 K to 30.7 K (+4.24 %) |
| Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 4,000 | 22,002 | 87,151 | |
| Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 132.20 | 200 | 26,440 | 15,977 | 16.2 K to 16 K (-1.24 %) |
| Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 131.75 | 2,459 | 323,979 | 16,177 | 18.6 K to 16.2 K (-13.19 %) |
| Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 130.37 | 1,341 | 174,830 | 18,636 | 20 K to 18.6 K (-6.71 %) |
| Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 4,000 | 22,002 | 19,977 | 16 K to 20 K (+25.04 %) |
| Sep 20 2017 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Option Exercise | A | 133.05 | 10,700 | 1,423,635 | 10,700 | |
| Sep 20 2017 | BLUE | bluebird bio, Inc. | Hedley Mary Lynne | Director | Grant | A | 0.00 | 2,700 | 0 | 2,700 | 0 to 2.7 K |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | M | 2.09 | 18,868 | 39,434 | 0 | |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 131.82 | 600 | 79,090 | 5,843 | 6.4 K to 5.8 K (-9.31 %) |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 131.19 | 18,268 | 2,396,643 | 6,443 | 24.7 K to 6.4 K (-73.93 %) |
| Sep 18 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Buy | M | 2.09 | 18,868 | 39,434 | 24,711 | 5.8 K to 24.7 K (+322.92 %) |
| Sep 14 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Option Exercise | M | 30.47 | 6,000 | 182,820 | 14,000 | |
| Sep 14 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 127.00 | 4,730 | 600,716 | 2,000 | 6.7 K to 2 K (-70.28 %) |
| Sep 14 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Sell | S | 126.15 | 1,270 | 160,207 | 6,730 | 8 K to 6.7 K (-15.87 %) |
| Sep 14 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Buy | M | 30.47 | 6,000 | 182,820 | 8,000 | 2 K to 8 K (+300.00 %) |
| Sep 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 4,900 | 26,952 | 67,485 | |
| Sep 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 126.43 | 1,418 | 179,280 | 27,305 | 28.7 K to 27.3 K (-4.94 %) |
| Sep 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 125.44 | 3,482 | 436,785 | 28,723 | 32.2 K to 28.7 K (-10.81 %) |
| Sep 13 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 4,900 | 26,952 | 32,205 | 27.3 K to 32.2 K (+17.95 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 25,750 | |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 126.60 | 700 | 88,620 | 29,484 | 30.2 K to 29.5 K (-2.32 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 125.82 | 1,550 | 195,015 | 30,184 | 31.7 K to 30.2 K (-4.88 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 31,734 | 30.5 K to 31.7 K (+4.10 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 12,000 | 66,005 | 91,151 | |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 130.01 | 9,000 | 1,170,112 | 15,977 | 25 K to 16 K (-36.03 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 126.60 | 700 | 88,620 | 24,977 | 25.7 K to 25 K (-2.73 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 126.16 | 2,300 | 290,173 | 25,677 | 28 K to 25.7 K (-8.22 %) |
| Sep 06 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 12,000 | 66,005 | 27,977 | 16 K to 28 K (+75.11 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 12,000 | 66,005 | 72,385 | |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 125.01 | 12,000 | 1,500,091 | 27,305 | 39.3 K to 27.3 K (-30.53 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 12,000 | 66,005 | 39,305 | 27.3 K to 39.3 K (+43.95 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Option Exercise | M | 8.16 | 2,000 | 16,312 | 19,361 | |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Sell | S | 115.07 | 2,000 | 230,145 | 3,176 | 5.2 K to 3.2 K (-38.64 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Buy | M | 8.16 | 2,000 | 16,312 | 5,176 | 3.2 K to 5.2 K (+62.97 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 5.50 | 500 | 2,750 | 23,342 | |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 120.00 | 500 | 60,000 | 2,800 | 3.3 K to 2.8 K (-15.15 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 5.50 | 500 | 2,750 | 3,300 | 2.8 K to 3.3 K (+17.86 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | M | 5.50 | 6,364 | 35,005 | 243,355 | |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 130.04 | 22,500 | 2,925,983 | 273,232 | 295.7 K to 273.2 K (-7.61 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Buy | M | 5.50 | 6,364 | 35,005 | 295,732 | 289.4 K to 295.7 K (+2.20 %) |
| Sep 05 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 115.09 | 24,333 | 2,800,461 | 289,368 | 313.7 K to 289.4 K (-7.76 %) |
| Aug 31 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 115.18 | 25,667 | 2,956,307 | 313,701 | 339.4 K to 313.7 K (-7.56 %) |
| Aug 31 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Gift | G | 0.00 | 10,000 | 0 | 339,368 | 349.4 K to 339.4 K (-2.86 %) |
| Aug 30 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 1,250 | 6,876 | 84,385 | |
| Aug 30 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 107.06 | 1,250 | 133,826 | 27,305 | 28.6 K to 27.3 K (-4.38 %) |
| Aug 30 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 1,250 | 6,876 | 28,555 | 27.3 K to 28.6 K (+4.58 %) |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | M | 2.09 | 13,839 | 28,924 | 18,868 | |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 96.74 | 2,754 | 266,425 | 5,843 | 8.6 K to 5.8 K (-32.03 %) |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 96.32 | 6,385 | 615,019 | 8,597 | 15 K to 8.6 K (-42.62 %) |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Sell | S | 95.13 | 4,700 | 447,089 | 14,982 | 19.7 K to 15 K (-23.88 %) |
| Aug 28 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Buy | M | 2.09 | 13,839 | 28,924 | 19,682 | 5.8 K to 19.7 K (+236.85 %) |
| Aug 15 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Sell | S | 95.95 | 1,000 | 95,950 | 1,000 | 2 K to 1,000 (-50.00 %) |
| Aug 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 1,250 | 6,876 | 85,635 | |
| Aug 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 95.41 | 1,250 | 119,265 | 27,305 | 28.6 K to 27.3 K (-4.38 %) |
| Aug 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 1,250 | 6,876 | 28,555 | 27.3 K to 28.6 K (+4.58 %) |
| Aug 09 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 500 | 25,255 | 27,000 | |
| Aug 09 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 99.00 | 750 | 74,250 | 30,484 | 31.2 K to 30.5 K (-2.40 %) |
| Aug 09 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 500 | 25,255 | 31,234 | 30.7 K to 31.2 K (+1.63 %) |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 56.30 | 244 | 13,737 | 8,558 | |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 50.51 | 201 | 10,153 | 5,868 | |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 24.47 | 166 | 4,062 | 854 | |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 20.70 | 250 | 5,175 | 750 | |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 95.21 | 445 | 42,370 | 5,674 | 6.1 K to 5.7 K (-7.27 %) |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 56.30 | 244 | 13,737 | 6,119 | 5.9 K to 6.1 K (+4.15 %) |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 50.51 | 201 | 10,153 | 5,875 | 5.7 K to 5.9 K (+3.54 %) |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 92.35 | 416 | 38,418 | 5,674 | 6.1 K to 5.7 K (-6.83 %) |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 24.47 | 166 | 4,062 | 6,090 | 5.9 K to 6.1 K (+2.80 %) |
| Aug 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 20.70 | 250 | 5,175 | 5,924 | 5.7 K to 5.9 K (+4.41 %) |
| Jul 12 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 2,500 | 13,751 | 86,885 | |
| Jul 12 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 100.50 | 57 | 5,729 | 27,305 | 27.4 K to 27.3 K (-0.21 %) |
| Jul 12 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 99.88 | 2,443 | 243,995 | 27,362 | 29.8 K to 27.4 K (-8.20 %) |
| Jul 12 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 2,500 | 13,751 | 29,805 | 27.3 K to 29.8 K (+9.16 %) |
| Jul 11 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 101.10 | 100 | 10,110 | 15,977 | 16.1 K to 16 K (-0.62 %) |
| Jul 11 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 100.43 | 1,100 | 110,473 | 16,077 | 17.2 K to 16.1 K (-6.40 %) |
| Jul 10 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 28,250 | |
| Jul 10 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 103.83 | 2,250 | 233,616 | 31,484 | 33.7 K to 31.5 K (-6.67 %) |
| Jul 10 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 33,734 | 32.5 K to 33.7 K (+3.85 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 22.53 | 5,126 | 115,489 | 31,686 | |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 22.53 | 5,126 | 115,489 | 20,927 | 15.8 K to 20.9 K (+32.44 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 56.30 | 2,933 | 165,128 | 8,802 | |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 50.51 | 201 | 10,153 | 6,069 | |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 24.47 | 196 | 4,796 | 1,020 | |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 20.70 | 250 | 5,175 | 1,000 | |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 107.22 | 733 | 78,595 | 5,674 | 6.4 K to 5.7 K (-11.44 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 107.29 | 3,580 | 384,111 | 6,407 | 10 K to 6.4 K (-35.85 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 56.30 | 2,933 | 165,128 | 9,987 | 7.1 K to 10 K (+41.58 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 50.51 | 201 | 10,153 | 7,054 | 6.9 K to 7.1 K (+2.93 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 24.47 | 196 | 4,796 | 6,853 | 6.7 K to 6.9 K (+2.94 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 20.70 | 250 | 5,175 | 6,657 | 6.4 K to 6.7 K (+3.90 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 2.09 | 5,000 | 10,450 | 4,239 | |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 106.05 | 100 | 10,605 | 17,177 | 17.3 K to 17.2 K (-0.58 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 105.26 | 4,900 | 515,790 | 17,277 | 22.2 K to 17.3 K (-22.09 %) |
| Jul 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 2.09 | 5,000 | 10,450 | 22,177 | 17.2 K to 22.2 K (+29.11 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 50.51 | 3,430 | 173,249 | 6,270 | |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 24.47 | 1,298 | 31,762 | 1,216 | |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 20.70 | 2,000 | 41,400 | 1,250 | |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 108.55 | 59 | 6,404 | 6,407 | 6.5 K to 6.4 K (-0.91 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 110.28 | 1,824 | 201,148 | 6,466 | 8.3 K to 6.5 K (-22.00 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 109.41 | 1,611 | 176,266 | 8,290 | 9.9 K to 8.3 K (-16.27 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 108.02 | 3,293 | 355,711 | 9,901 | 13.2 K to 9.9 K (-24.96 %) |